투자판단관련주요경영사항(임상시험계획승인신청등결정) (HUC1-394(NCP112)점안제 제 2상 임상시험의 한국 임상시험계획(IND) 승인)[코]
Received: 3/11/2026 · Reporter: 휴온스
A summary for this filing type is not yet available. Please refer to the original DART filing.
🏢 Past 12 months filing pattern (this company)
- Total filings
- 58 filings
- Same category
- 36 filings
- Previous same-category filing
- 8/4/2026
- Corrections / withdrawals
- 5 filings
Filing source / License
The original PDF/HTML of this filing is provided by FSS DART. MarketBubbles displays only metadata (title, receipt number, type, reporter) and a rule-based summary; we do not mirror the original PDF body (per FSS ToS).